Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | $52.99 | $60.69 | -12.69% | 28.64x | 13.16x | 9.69x | 5.57x | 0.36x | $105.42M | 3.82% | $495.80M | 9.52 | $2.68B | 24.94 | ||
| LQDA | LIQUIDIA CORP | $59.30 | $17.58 | 237.24% | 247.08x | 21.93x | 18.12x | 48.57x | 1.25x | $41.15M | 0.79% | $108.58M | 1.23 | $5.23B | 97.67 | ||
| ADMA | ADMA BIOLOGICS INC | $8.50 | $11.76 | -27.69% | 12.32x | 8.56x | 3.94x | 5.05x | 0.36x | $107.90M | 5.38% | $390.33M | 1.65 | $2.03B | 9.16 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $293.45 | $98.54 | 197.80% | 67.31x | 41.39x | 9.10x | 36.43x | 1.34x | $641.34M | 1.64% | $1.08B | 8.09 | $40.44B | 43.74 | ||
| CORT | CORCEPT THERAPEUTICS INC | $58.30 | $16.18 | 260.22% | 126.74x | 107.45x | 7.92x | 9.81x | 1.45x | $119.79M | 1.97% | $637.99M | 6.11 | $6.16B | -897.10 | ||
| KRYS | KRYSTAL BIOTECH INC | $316.30 | $102.49 | 208.62% | 40.81x | 40.23x | 22.20x | 7.30x | 1.78x | $237.38M | 2.56% | $1.28B | 43.59 | $8.83B | 41.28 | ||
| ASND | ASCENDIS PHARMA A | $245.49 | $103.71 | 136.70% | 26.02x | 57.55x | 14.97x | 26.56x | 1.58x | $52.94M | 0.35% | $574.09M | 9.24 | $15.63B | 167.59 | ||
| OMER | OMEROS CORP | $13.28 | $17.93 | -25.95% | 10.22x | -21.83x | 96.23x | -15.18x | 0.41x | -$94.78M | -9.92% | -$63.33M | -0.88 | $1.27B | 14.04 | ||
| HALO | HALOZYME THERAPEUTICS INC | $69.21 | $71.67 | -3.43% | 23.38x | 8.39x | 5.42x | 37.38x | 0.42x | $667.65M | 8.17% | $219.64M | 1.86 | $10.04B | 16.10 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.38 | $2.86 | 122.96% | 91.14x | 53.39x | 3.46x | 84.66x | 0.88x | $47.52M | 4.37% | $13.01M | 0.08 | $1.25B | 23.36 | ||
| VCEL | VERICEL CORP | $33.14 | $8.77 | 277.97% | 77.07x | 74.69x | 5.76x | 4.75x | 1.76x | $47.49M | 2.82% | $356.23M | 7.02 | $1.68B | 41.51 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.66 | $16.36 | -28.72% | 5.69x | 23.52x | 5.57x | 3.35x | 0.74x | $56.42M | 8.28% | $205.80M | 3.52 | $594.83M | 4.11 | ||
| RPRX | ROYALTY PHARMA PLC | $53.40 | $42.19 | 26.56% | 27.96x | 10.09x | 9.56x | 3.09x | 0.57x | $2.34B | 10.04% | $9.94B | 22.75 | $39.12B | 33.62 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.80 | $3.03 | 25.50% | 15.83x | 13.92x | 2.33x | 3.68x | 0.75x | $4.11M | 1.34% | $82.33M | 1.03 | $238.68M | 11.24 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $53.24 | $41.75 | 27.53% | 38.03x | 11.78x | 3.16x | 1.66x | 0.53x | $767.06M | 7.48% | $6.21B | 32.27 | $8.65B | 17.92 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $58.54 | $16.19 | 261.63% | 59.73x | 53.07x | 5.94x | 7.44x | 1.83x | $164.23M | 3.67% | $605.69M | 7.92 | $4.32B | 38.78 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $231.05 | $49.21 | 369.52% | 491.60x | 9.49x | 3.22x | 3.20x | 1.69x | $1.30B | 9.07% | $4.53B | 73.22 | $18.05B | 26.75 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.60 | $6.98 | -19.82% | 4.48x | -6.79x | 21.79x | 2.20x | 6.92x | -$85.24M | -26.88% | $144.94M | 2.56 | $280.97M | 3.83 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $30.76 | $35.66 | -13.74% | 12.16x | 8.62x | 1.98x | 1.96x | 0.48x | $341.79M | 19.22% | $910.35M | 15.75 | $1.35B | 5.70 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.76 | $5.84 | -52.74% | 10.22x | 4.04x | 2.58x | 3.02x | 0.22x | $7.24M | 4.57% | $52.93M | 0.92 | $106.15M | 6.85 | ||
| TECH | BIO-TECHNE CORP | $44.74 | $16.62 | 169.20% | 63.01x | 22.13x | 5.78x | 3.36x | 1.20x | $269.60M | 3.86% | $2.09B | 13.34 | $7.09B | 27.68 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.16 | $14.54 | 114.37% | 17.22x | 15.09x | 6.38x | 3.77x | 2.21x | $208.13M | 5.46% | $1.01B | 8.28 | $3.06B | 9.14 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $218.98 | $82.30 | 166.07% | 27.72x | 23.74x | 15.86x | 4.40x | 1.88x | $122.22M | 2.81% | $997.32M | 50.16 | $4.73B | 20.95 | ||
| UTHR | UNITED THERAPEUTICS CORP | $575.79 | $265.32 | 117.01% | 19.66x | 19.53x | 7.90x | 4.14x | 1.82x | $1.02B | 4.06% | $5.90B | 135.66 | $23.16B | 13.52 | ||
| EXEL | EXELIXIS INC | $51.10 | $31.38 | 62.85% | 16.38x | 16.28x | 5.56x | 6.64x | 1.19x | $917.69M | 6.95% | $1.94B | 7.49 | $12.79B | 12.11 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $18.68 | $6.83 | 173.32% | 31.13x | 5.86x | 0.90x | 1.31x | 1.77x | $109.24M | 5.57% | $1.51B | 14.34 | $2.54B | 30.75 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $450.41 | $176.98 | 154.50% | 26.48x | 23.13x | 9.37x | 5.90x | 1.80x | $3.71B | 3.24% | $19.36B | 76.20 | $110.81B | 20.55 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.00 | $1.77 | 12.78% | 10.53x | 9.21x | 2.09x | 2.40x | 0.91x | $13.00M | 8.15% | $67.23M | 0.84 | $127.91M | 5.73 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $712.87 | $437.38 | 62.99% | 16.75x | 15.13x | 4.97x | 2.38x | 1.17x | $4.11B | 5.55% | $31.42B | 302.15 | $74.48B | 12.96 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $7.19 | $4.37 | 64.52% | 14.38x | 17.62x | 1.61x | 2.85x | 1.46x | $53.60M | 14.66% | $128.42M | 2.53 | $343.64M | 7.64 | ||
| MDXG | MIMEDX GROUP INC | $3.55 | $1.79 | 97.78% | 16.90x | -261.03x | 1.35x | 2.18x | 1.82x | $69.36M | 13.15% | $242.94M | 1.64 | $386.58M | 7.10 | ||
| INCY | INCYTE CORP | $97.63 | $67.81 | 43.98% | 13.39x | 12.46x | 3.63x | 3.47x | 1.16x | $1.45B | 7.45% | $5.62B | 28.21 | $16.08B | 8.59 | ||
| VCYT | VERACYTE INC | $38.90 | $9.04 | 330.16% | 35.05x | 42.53x | 5.71x | 2.31x | 4.31x | $155.34M | 5.02% | $1.34B | 16.90 | $2.88B | 25.02 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.